Panel Discussion: Setting up Global Clinical Trials with the End in Mind

Time: 3:30 pm
day: Track 2, Day 1 PM


• Is the evolving regulatory landscape requiring greater generation of relevant and reliable real world evidence to prove pre-market clinical performance?

• How do analytical parameters of precision medicine testing influence and augment clinical utility and outcome?

• Differentiators between US & EU locations for supporting streamlined drug and companion diagnostic regulatory strategy execution and submissions